Redmile Group LLC purchased a new position in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,770,600 shares of the software maker’s stock, valued at approximately $25,762,000.
A number of other large investors have also recently made changes to their positions in the business. Jane Street Group LLC boosted its holdings in Allscripts Healthcare Solutions by 89.3% in the fourth quarter. Jane Street Group LLC now owns 114,068 shares of the software maker’s stock worth $1,660,000 after acquiring an additional 53,801 shares in the last quarter. Zeke Capital Advisors LLC bought a new position in Allscripts Healthcare Solutions in the fourth quarter worth approximately $165,000. Flinton Capital Management LLC boosted its holdings in Allscripts Healthcare Solutions by 30.3% in the fourth quarter. Flinton Capital Management LLC now owns 23,940 shares of the software maker’s stock worth $348,000 after acquiring an additional 5,572 shares in the last quarter. Elkfork Partners LLC bought a new position in Allscripts Healthcare Solutions in the fourth quarter worth approximately $274,000. Finally, Teachers Advisors LLC boosted its holdings in Allscripts Healthcare Solutions by 14.2% in the fourth quarter. Teachers Advisors LLC now owns 1,449,500 shares of the software maker’s stock worth $21,090,000 after acquiring an additional 180,099 shares in the last quarter.
In related news, EVP Brian Farley sold 5,000 shares of the stock in a transaction that occurred on Wednesday, March 14th. The stock was sold at an average price of $13.73, for a total transaction of $68,650.00. Following the completion of the sale, the executive vice president now directly owns 240,672 shares of the company’s stock, valued at $3,304,426.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Richard J. Poulton sold 15,000 shares of the stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $13.53, for a total value of $202,950.00. Following the sale, the president now directly owns 505,920 shares of the company’s stock, valued at $6,845,097.60. The disclosure for this sale can be found here. Company insiders own 0.75% of the company’s stock.
Several brokerages have recently commented on MDRX. BidaskClub raised Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research note on Wednesday, December 20th. Citigroup began coverage on Allscripts Healthcare Solutions in a research note on Thursday, January 4th. They issued a “buy” rating for the company. Cantor Fitzgerald reissued a “buy” rating and issued a $17.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Monday, January 8th. Maxim Group reissued a “buy” rating and issued a $20.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Tuesday, January 9th. Finally, Royal Bank of Canada set a $19.00 price objective on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research note on Thursday, January 11th. One analyst has rated the stock with a sell rating, six have issued a hold rating and twelve have issued a buy rating to the company. Allscripts Healthcare Solutions currently has a consensus rating of “Buy” and a consensus price target of $16.09.
Shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) opened at $13.17 on Friday. The company has a current ratio of 0.97, a quick ratio of 0.97 and a debt-to-equity ratio of 1.33. The company has a market capitalization of $2,381.81, a P/E ratio of 28.02, a P/E/G ratio of 1.70 and a beta of 1.20. Allscripts Healthcare Solutions Inc has a 52-week low of $11.25 and a 52-week high of $16.13.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings results on Thursday, February 15th. The software maker reported $0.18 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.18. The company had revenue of $547.00 million during the quarter, compared to the consensus estimate of $524.05 million. Allscripts Healthcare Solutions had a positive return on equity of 7.36% and a negative net margin of 10.88%. Allscripts Healthcare Solutions’s revenue was up 27.5% on a year-over-year basis. During the same period last year, the business posted $0.14 earnings per share. research analysts anticipate that Allscripts Healthcare Solutions Inc will post 0.56 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This story was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/03/18/redmile-group-llc-takes-25-76-million-position-in-allscripts-healthcare-solutions-inc-mdrx.html.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.